March 11, 2020 / 11:21 AM / in 18 days

BRIEF-Kamada Plans To Initiate Development Of An Anti-Corona (COVID-19) Polyclonal Immunoglobulin

March 11 (Reuters) - Kamada Ltd:

* KAMADA PROVIDES UPDATE ON PROGRESS RELATED TO ITS PROPRIETARY HYPER-IMMUNOGLOBULIN (IGGS) PLATFORM TECHNOLOGY INCLUDING ITS COMMERCIAL ANTI-RABIES IGG AND ITS PIPELINE PRODUCTS ANTI-CORONA (COVID-19) AND ANTI-ZIKA IGGS

* KAMADA LTD - PLANS TO INITIATE DEVELOPMENT OF AN ANTI-CORONA (COVID-19) POLYCLONAL IMMUNOGLOBULIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below